Clearmind Medicine (CMND) Earnings Analysis

Clearmind Medicine (CMND) has no confirmed upcoming earnings date. Trailing P/E -0.14.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CMND next report earnings?

No confirmed upcoming earnings date is currently scheduled for CMND. This page updates as the calendar is published.

CMND earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-06-15-6.78 USDn/an/an/a
2026-03-12-3.32 USDn/an/an/a
2026-01-28-4.4 USDn/an/an/a
2025-09-11-10 USDn/an/an/a
2025-06-12-6.4 USDn/an/an/a
2025-03-13-9.6 USDn/an/an/a
2025-01-22-0.11 USDn/an/an/a
2024-09-16-0.59 USDn/an/an/a

CMND valuation and analyst view

Trailing P/E-0.14
Trailing EPS-26.16624 USD
Price / book0.04
Dividend yield0.00%
Market cap0.00B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Clearmind Medicine (CMND)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for CMND. This page updates as the calendar is published.

Did CMND beat earnings last quarter?

Consensus estimate data was not available for CMND's 2026-06-15 report.

What is CMND's current P/E ratio and EPS?

CMND trades at a trailing P/E of -0.14 on trailing EPS of -26.166235047886502 USD.

What do analysts rate CMND?

CMND has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.